Abbott Laboratories Guides FY24 Adj. EPS In Line With Estimates – Update

From Nasdaq.:

Abbott Laboratories reported its financial results for the fourth quarter and issued guidance for the full-year 2024. The company expects earnings of $3.20 to $3.40 per share and adjusted earnings of $4.50 to $4.70 per share for fiscal 2024. Analysts predict earnings of $4.64 per share for the year. For more earnings news and calendar, visit rttnews.com.



Read more: Abbott Laboratories Guides FY24 Adj. EPS In Line With Estimates – Update